WAY-328173

CAS No. 912790-59-1

WAY-328173( —— )

Catalog No. M29009 CAS No. 912790-59-1

WAY-328173 is a Wnt/beta-catenin agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 70 In Stock
5MG 65 In Stock
10MG 104 In Stock
25MG 217 In Stock
50MG 346 In Stock
100MG 555 In Stock
200MG 783 In Stock
500MG 1172 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-328173
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-328173 is a Wnt/beta-catenin agonist.
  • Description
    WAY-328173 is a Wnt/beta-catenin agonist.
  • In Vitro
    Western Blot Analysis Cell Line:HEK293 cells Concentration:30 and 60 μM Incubation Time:24 hours Result:Deposited β-catenin in a dose-dependent pattern within cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Wnt/beta/catenin
  • Recptor
    Wnt/beta-catenin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    912790-59-1
  • Formula Weight
    330.77
  • Molecular Formula
    C16H15ClN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (377.91 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • IWR-1-endo

    IWR-1(IWR-1-endo) is a novel small-molecule inhibitor of Wnt signaling by stabilizing the Axin destruction complex with an EC50 of 0.2 uM.

  • β-Elemonic Acid

    Beta-Elemonic acid inhibits proliferation by inducing hypoploid cells and cell apoptosis, the anticancer effects of beta-Elemonic acid are related to the MAPK signaling pathway, ROS activation and glutathione depletion in human A549 lung cancer cells.

  • Wnt pathway activato...

    Wnt pathway activator 1 is a potent Wnt activator with an IC50 of 28-29 nM. Wnt pathway activator 1 is a potent Wnt activator for the treatment of androgenetic alopecia (AGA) extracted from patent WO2012024404A1.